SPEAC Newsletter Fall/Winter 2025 Edition
January 30, 2026
We are pleased to share recent updates from the Safety Platform for Emergency vACcines (SPEAC), including new safety tools, evidence resources, and global engagement
We are pleased to share recent updates from the Safety Platform for Emergency vACcines (SPEAC), including new safety tools, evidence resources, and global engagement
As 2025 draws to a close, we pause to reflect on a year defined by collaboration, learning, and shared commitment across the global vaccine
SPEAC’s mission has always centered on strengthening the foundations of vaccine safety—through tools, guidance, and evidence, in support of the people who make real-time
We are pleased to share that six members of the SPEAC team—Andy Stergachis, Esperança Sevene, Mohammad Gazi Shah Alam, Samantha Mudigonda, Dale Nordenberg, and
The SPEAC Project has released an updated list of Adverse Events of Special Interest (AESI) for Marburg virus disease (MVD) vaccines, v2.1. This update
The SPEAC Project has released an updated list of Adverse Events of Special Interest (AESI) for Rift Valley fever (RVF) vaccines. This update reflects the
The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.
© SPEAC 2023. All rights reserved.